Population Impact of HPV Vaccines: Summary of Early Evidence

Details

• Alternative Title:
  J Adolesc Health
• Personal Author:
  Hariri, Susan ; Markowitz, Lauri E. ; Dunne, Eileen F. ; Unger, Elizabeth R.
• Description:
  Human papillomavirus (HPV) vaccines are available in the United States and around the world to prevent HPV-associated diseases including cervical cancer and genital warts. HPV vaccination is currently recommended for adolescents: target ages for routine and catch-up vaccinations vary by country. Because the time from vaccination to cancer development can be several decades, many studies are evaluating more immediate outcomes. In the 4 years since the vaccine was introduced, reductions in HPV vaccine type prevalence and genital warts have been reported in young females in the United States and other countries. Many questions remain about the long-term impact, but the initial studies show promising results for the relatively new HPV vaccine.
• Subjects:
  Adolescent Adult Article Cervical Cancer Condylomata Acuminata Female Global Health HPV Vaccine Humans Male Papillomavirus Infections Papillomavirus Vaccines Prevention Uterine Cervical Neoplasms

  More +
• Source:
  J Adolesc Health. 53(6):679-682
• Pubmed ID:
  24263069
• Pubmed Central ID:
  PMC7499050
• Document Type:
  Journal Article
• Funding:
  CC999999/ImCDC/Intramural CDC HHS/United States
• Volume:
  53
• Issue:
  6
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:16586b71cf2591c28485358d9331eb774323bb52a2f02b62fffd91902723c76f
• Download URL:
  https://stacks.cdc.gov/view/cdc/93863/cdc_93863_DS1.pdf
• File Type:
  [PDF - 53.08 KB ]